Search

Roivant Sciences Ltd

Chiusa

SettoreSettore sanitario

35.97 -0.88

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

35.4

Massimo

36.48

Metriche Chiave

By Trading Economics

Entrata

669M

356M

Vendite

521K

2.5M

Margine di Profitto

14,116.825

Dipendenti

721

EBITDA

744M

455M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+1.13% upside

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

5.6B

26B

Apertura precedente

36.85

Chiusura precedente

35.97

Notizie sul Sentiment di mercato

By Acuity

24%

76%

76 / 342 Classifica in Healthcare

Roivant Sciences Ltd Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

7 lug 2026, 23:51 UTC

News

Netflix is reportedly bidding for FIFA World Cup U.S. rights valued at $2 billion, boosting positive sentiment as shares rise in after-market trading.

7 lug 2026, 23:43 UTC

Social Media
News

Apple Inc. shares rose in after-hours trading, bolstered by a significant gain in a call option and an extended partnership with Broadcom through 2031.

7 lug 2026, 23:41 UTC

News

Concerns over Middle East tensions and rising oil prices support gains in iShares 7-10 Year Treasury Bond ETF during after-hours trading.

7 lug 2026, 23:41 UTC

Social Media
Correlated Moves
News

NVIDIA shares are lower in after-market trading as Michael Burry initiates short positions, citing concerns over reduced AI spending among businesses.

7 lug 2026, 23:41 UTC

Macro News
ETF Constituents
News

Vanguard Information Technology ETF is higher in after-market trading, supported by gains from key holdings despite broader market pressures and geopolitical tensions.

7 lug 2026, 23:41 UTC

ETF Constituents
Social Media
News

Geopolitical tensions following U.S. strikes against Iran have contributed to a decline in Invesco QQQ Trust during after-market hours, reflecting broader market concerns.

7 lug 2026, 23:36 UTC

ETF Constituents
News

Geopolitical tensions following U.S. strikes against Iran have contributed to a decline in the Vanguard Growth ETF during after-market hours.

7 lug 2026, 23:21 UTC

Social Media
News

Meta Platforms Inc. has gained after launching its Muse Image generator, enhancing user engagement despite facing $1.4 trillion in legal challenges.

7 lug 2026, 23:06 UTC

News

Geopolitical tensions rise after U.S. strikes on Iran, while the Reserve Bank of New Zealand is set to announce a rate hike. The ETF traded roughly flat in after-market hours.

7 lug 2026, 23:06 UTC

News

The United States Oil Fund LP is trading higher after military strikes against Iran escalated tensions, contributing to gains in WTI crude prices above $72.50.

7 lug 2026, 23:06 UTC

News
Social Media
Correlated Moves

Micron Technology Inc. shares are lower in after-market trading amid broader market declines and concerns over chip stocks following Samsung's earnings report.

7 lug 2026, 23:02 UTC

Correlated Moves
News

Silver is lower in after-market hours, reflecting declines since Tuesday's close amid rising tensions from U.S. military actions and expectations of a New Zealand rate hike.

7 lug 2026, 23:01 UTC

ETF Constituents
Macro News
News

The Industrial Select Sector SPDR Fund declined in after-market hours amid geopolitical tensions and a hawkish Fed stance, impacting operating margins in the industrial sector.

7 lug 2026, 23:01 UTC

Social Media
News

T-Mobile US Inc. appointed Chris Sambar as Chief Enterprise Officer, effective by October 14, 2026, and shares traded higher in after-market hours.

7 lug 2026, 22:51 UTC

News

PayPal shares are lower in after-market hours following Barclays' Underweight rating and price target of $42.00, amid broader market weakness and geopolitical tensions.

7 lug 2026, 20:07 UTC

News
Correlated Moves

Bitcoin declines amid geopolitical tensions following missile attacks in the Strait of Hormuz. Regulatory approval for Bitcoin Suisse in the UAE adds complexity to investor sentiment.

7 lug 2026, 20:07 UTC

Correlated Moves
News

Bitcoin is lower today amid rising geopolitical tensions and concerns over oil supply disruptions. Ethereum's decline may also influence Bitcoin's price movement.

7 lug 2026, 20:06 UTC

Social Media
News
Correlated Moves

Synopsys Inc. is discontinuing its manufacturing process control software for semiconductor makers, shifting focus to AI design offerings. Shares are trading lower today.

7 lug 2026, 20:06 UTC

Social Media
News

Amazon.com Inc shares are higher following a $25 billion bond sale to fund AI infrastructure, attracting $62 billion in demand and receiving an 'AA-' rating from Fitch.

7 lug 2026, 20:06 UTC

News
Social Media
Correlated Moves

Broadcom Inc shares are lower today following a downgrade to Hold by Erste Group, amid broader declines in the semiconductor sector.

7 lug 2026, 20:06 UTC

News
Correlated Moves

Ethereum is trading lower following a suspicious transaction linked to an exploiter, resulting in estimated losses of around $6 million.

7 lug 2026, 20:04 UTC

News
Social Media

Tesla Inc. shares are lower today amid criticism of CEO Elon Musk's governance linked to negative brand perception, despite RBC raising its price target to $500.

7 lug 2026, 20:03 UTC

Social Media
News

Fiserv is in talks to sell its debit card network for about $15 billion. Shares are trading lower amid market volatility despite earlier gains.

7 lug 2026, 20:03 UTC

News
Correlated Moves

Analog Devices has completed its acquisition of Empower Semiconductor to enhance AI capabilities. Shares are declining amid broader market pressures affecting the semiconductor sector.

7 lug 2026, 20:02 UTC

Correlated Moves
News

IDEXX Laboratories is rising amid strong gains in the Health Care Equipment sector. Analysts highlight IDEXX's innovations as key to maintaining market share.

7 lug 2026, 19:52 UTC

Social Media
News
Correlated Moves

Alphabet Inc. is under investigation in Nigeria for alleged anti-competitive practices, contributing to a decline in shares during Tuesday's session.

7 lug 2026, 19:46 UTC

News
Social Media
Correlated Moves

Costco faces scrutiny from a class-action lawsuit alleging toxic heavy metals in its protein products, contributing to shares trading lower since Monday's close.

7 lug 2026, 19:44 UTC

News

Intuitive Surgical Inc is down today, reversing from earlier gains amid notable volatility. The company continues to benefit from strong market positioning in robotic-assisted surgery.

7 lug 2026, 19:36 UTC

News
Correlated Moves

Ethereum is trading lower amid a suspicious transaction linked to an exploiter, resulting in estimated losses of $6 million and concerns over price manipulation.

7 lug 2026, 19:36 UTC

News
Social Media

Vertex Pharmaceuticals shares are lower today following its $10 billion acquisition of Crinetics Pharmaceuticals, despite analyst support and price target increases.

Confronto tra pari

Modifica del prezzo

Roivant Sciences Ltd Previsione

Obiettivo di Prezzo

By TipRanks

1.13% in crescita

Previsioni per 12 mesi

Media 36.72 USD  1.13%

Alto 42 USD

Basso 29.29 USD

Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Roivant Sciences Ltd - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

8 ratings

7

Acquista

1

Mantieni

0

Vendi

Sentiment

By Acuity

76 / 342 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Roivant Sciences Ltd

Roivant Sciences Ltd., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas. The company provides Vants, a model to develop and commercialize its medicines and technologies focusing on biopharmaceutical businesses, discovery-stage companies, and health technology startups. It offers VTAMA, a novel topical approved for the treatment of psoriasis and in development for the treatment of atopic dermatitis; IMVT-1402 and batoclimab, which are fully human monoclonal antibodies that targets the neonatal Fc receptor in development across various IgG-mediated autoimmune indications; brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis and non-infectious uveitis, as well as for other therapies in various stages of clinical development; and Namilumab, a fully human anti-GM-CSF monoclonal antibody under Phase 2 clinical trial for the treatment of inflammatory and autoimmune diseases. The company also provides delivery platforms comprising lipid nanoparticle platform and ligand conjugate platform. It has collaboration and license agreements with Boehringer Ingelheim International, GmbH for conducting discovery work on RNA-specific adenosine deaminase 1 targeting and modulating compounds; and with Japan Tobacco Inc. for the rights to develop, register, and market tapinarof in Japan for the treatment of psoriasis and atopic dermatitis. The company was founded in 2014 and is based in London, the United Kingdom.
help-icon Live chat